Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Potential biomarker discovered for brain tumors in children

researcher in lab © Medical University of Vienna/Houdek

This was shown by a study conducted at the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital within the framework of the Comprehensive Cancer Center (CCC) and in collaboration with the German Cancer Research Center in Heidelberg.

The new study by Johannes Gojo, junior doctor and researcher at the Department of Pediatrics and Adolescent Medicine of MedUni Vienna and Vienna General Hospital and member of the CCC, investigated whether the enzyme telomerase could be used as a biomarker for ependymomas. Gojo states: "We were able to show that telomerase was primarily reactivated in tumors that exhibit a particularly aggressive course. This means that the tumor recurred despite surgical removal and subsequent radiotherapy and chemotherapy." The scientists suspect that this will enable them to identify patients who would benefit from more intensive treatment. Conversely, patients with less aggressive tumors could be spared chemotherapy. This would mean a huge improvement in the quality of life for those affected. "Together with other parameters, the presence of telomerase could be a big help in deciding on the course of treatment. It therefore represents a highly promising biomarker.” The study was published in the leading scientific journal Nero-Oncology.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ESIB 2019

    18. - 20.11.2019, Graz, Austria

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

Unexpected role of mTORC2 protein in colorectal cancer

New results from researchers at the Centre for Pathobiochemistry and Genetics at the Medical University of Vienna show that a protein called mTORC2, which is the target of newly developed cancer drugs, is not even active in colorectal cancer.

Insider Tip: FinTech Location Vienna

Startups and key players on the scene will gather together at the upcoming Fintech Week Vienna (18 – 24 November 2019) with the European Fintech Summit on 19 November as the highlight. Vienna, which is (still) underestimated as a European FinTech hotspot, not only spawns its own world-renowned start-ups but also attracts international FinTech companies.

More news All blog posts